Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream Infections

Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health

(2012) George H. Talbot et al.   CLINICAL INFECTIOUS DISEASES

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

(2012) D. R. Andes et al.   CLINICAL INFECTIOUS DISEASES

Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis

(2012) C.-L. Lu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium

(2011) George Sakoulas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Management of multidrug-resistant enterococcal infections

(2011) C.A. Arias et al.   CLINICAL MICROBIOLOGY AND INFECTION

Vancomycin-resistant Enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin

(2011) Jennifer D. Twilla et al.   Journal of Hospital Medicine

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study

(2011) Ravina Kullar et al.   PHARMACOTHERAPY

The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

(2010) Mini Kamboj et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

(2010) Christopher W. Crank et al.   CLINICAL THERAPEUTICS

Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents

(2010) J. A. McKINNELL et al.   EPIDEMIOLOGY AND INFECTION

Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

(2010) Shawna Kraft et al.   SUPPORTIVE CARE IN CANCER

Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy

(2009) Pamela A Moise et al.   ANNALS OF PHARMACOTHERAPY

Secular Trends of Hospitalization With Vancomycin-Resistant Enterococcus Infection in the United States, 2000–2006

(2009) Andrew M. Ramsey et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

(2009) V. Mave et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004

(2008) Rebecca Reik et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

(2008) Alicia I. Hidron et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

(2008) I. Florescu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype

(2008) J.-H. Song et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia

(2007) K. M. Erlandson et al.   CLINICAL INFECTIOUS DISEASES